MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Tempest Therapeutics, Inc. (TPST)

Tempest Therapeutics, Inc. (TPST)

|||

Balance Sheets Overview

Current Ratio
38.13%
Quick Ratio
38.13%
Cash Ratio
17.51%
Debt to Asset Ratio
111.32%
Unit: Thousand (K) dollars
Assets Breakdown
    • Operating lease right-of-use ass...
    • Less accumulated depreciation
    • Cash and cash equivalents
    • Other noncurrent assets
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Operating lease liabilities, les...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
779
1,805
7,707
7,514
Prepaid expenses and other current assets
918
641
562
590
Total current assets
1,697
2,446
8,269
8,104
Property and equipment
2,058
2,058
2,058
2,203
Less accumulated depreciation
1,572
1,513
1,453
1,522
Property and equipment-net
486
545
605
681
Operating lease right-of-use assets
6,949
7,248
7,540
7,825
Other noncurrent assets
501
509
517
519
Total assets
9,633
10,748
16,931
17,129
Accounts payable
1,995
585
1,038
922
Accrued expenses
715
1,162
937
1,353
Current loan payable (net of discount and issuance costs of nil and 74, respectively)
-
-
0
0
Current operating lease liabilities
1,287
1,239
1,192
1,147
Accrued compensation
453
325
147
103
Interest payable
-
-
0
0
Total current liabilities
4,450
3,311
3,314
3,525
Operating lease liabilities, less current portion
6,273
6,615
6,949
7,258
Total liabilities
10,723
9,926
10,263
10,783
Common stock, 0.001 par value 100,000,000 shares authorized 15,979,404 and 4,927,161 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
16
14
5
4
Additional paid-in capital
274,210
270,880
240,031
235,689
Accumulated deficit
-275,316
-270,072
-233,368
-229,347
Total stockholders equity
-1,090
822
6,668
6,346
Total liabilities and stockholders equity
9,633
10,748
16,931
17,129
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$918K (11.54%↑ Y/Y)Cash and cashequivalents$779K (-94.54%↓ Y/Y)Property and equipment$2,058K (-6.58%↓ Y/Y)Operating leaseright-of-use assets$6,949K (-14.25%↓ Y/Y)Total current assets$1,697K (-88.76%↓ Y/Y)Other noncurrentassets$501K (-5.29%↓ Y/Y)Property andequipment-net$486K (-35.03%↓ Y/Y)Less accumulateddepreciation$1,572K (8.04%↑ Y/Y)Total assets$9,633K (-60.66%↓ Y/Y)Accumulated deficit-$275,316K (-21.91%↓ Y/Y)Total liabilities andstockholders equity$9,633K (-60.66%↓ Y/Y)Total stockholdersequity-$1,090K (-111.14%↓ Y/Y)Additional paid-in capital$274,210K (16.38%↑ Y/Y)Common stock, 0.001 parvalue 100,000,000...$16K (300.00%↑ Y/Y)Total liabilities$10,723K (-27.06%↓ Y/Y)Operating leaseliabilities, less current...$6,273K (-17.02%↓ Y/Y)Total currentliabilities$4,450K (-37.68%↓ Y/Y)Accounts payable$1,995K (-57.70%↓ Y/Y)Current operating leaseliabilities$1,287K (16.68%↑ Y/Y)Accrued expenses$715K (-41.44%↓ Y/Y)Accrued compensation$453K (348.51%↑ Y/Y)